References to specific products, dosing schedules, or clinical protocols in this article are for informational and educational purposes only and do not constitute an endorsement of any specific treatment approach
The hAMY 3 R cells were cultured in growth medium consisting of DMEM (Gibco, #31966-021) supplemented with 10% v/v FBS (Gibco, #16140-071), 1% v/v Penicillin-Streptomycin (Gibco, #15140-122), 0.5 mg/mL Geneticin G418 (Gibco, #10131-027), 0.4 mg/mL Hygromycin (Invitrogen, #10687010) and 250 nM Methotrexate (Sigma, A6770)
While clinical trials conducted in Croatia in the early 2000s determined BPC 157 to be safe and effective in humans for the treatment of inflammatory bowel disease, there appears to be a lack of trials conducted in the U.S
Purnima Balla, MD, at JuicyFace enhance my skin with glutathione injections
IV NAD therapies are not FDA-approved , have no standardized dosing, and may cause nausea, flushing, anxiety, or tachycardia
Patients should contact their healthcare provider if they experience excessive thirst (polydipsia) that persists despite adequate fluid intake, as this may signal uncontrolled diabetes or other metabolic disturbances